마이알고

It is difficult for general consumers to design personalized nutritional supplements based on their health data (symptoms, eating habits, activity levels, etc.). Existing wellness services are limited to questionnaires or simple recommendations and do not reflect complex individual health conditions in real-time. In addition, the rate of taking nutritional supplements is very low (around ~3% even with expert information), making it difficult to connect to actual health management.

Algocare's MyAlgo is a system that records the user's daily health status in real-time and AI automatically manufactures and distributes nutritional supplements. By linking an IoT-based dispenser and app, when the user presses the condition button every day, the AI combines it with long-term health data to create the necessary nutrient blend for that day.

This overcomes the existing manual intake rate (3.4%) (achieving a daily participation rate of 96%) and expands individual hospital-level nutritional management services to the home. It is unique in that it uses GraphRAG-based long-term memory AI to act as a doctor and provide proactive health management solutions.

Targeting the B2C (general household) market, consumers who are interested in health can purchase directly. It can also be applied to group programs (B2B) for health management such as companies, professional sports teams, and entertainment groups, as well as medical institutions such as hospitals and healthcare centers (B2B/B2G).

It is about to be launched and has a scale model in mind, from high-end consulting customers such as professional athletes to general household use.

The core technology (nutrition AI, device) can be applied to the global market. However, the marketability of health and nutrition management products, which are the main targets, may vary depending on the regulations of each country (classification of medical devices vs. general products) and health policies.

It is essential to establish a distribution network for hardware (dispenser) and consumables (nutritional supplements), and certification processes such as Europe FDA are required. There is room for expansion into other fields such as agriculture and animal health (e.g., customized animal feed).

At CES, it was introduced as an "AI healthcare anchor that goes beyond existing limitations." Many media outlets are paying attention to the global innovation case of Korean startups. The usability and technology have already been introduced in detail in the Dong-A Ilbo DBR, and the market response is also positive, with over 1,000 pre-orders.

The level of technological completeness is pre-clinical, but it is highly evaluated for having a stable algorithm. Market expectations are high, but initial demand may be limited due to the high price. The key is how well it overcomes regulatory (medical device certification) issues and high barriers to entry.